General Information
Version
DRE-C13201270 - Ergocryptine
Revision date
2023-06-06
Product name
Ergocryptine
Substance name
C ₃₂H₄₁N₅O₅ 575.69
Chemical name
Ergocryptine
CAS No.
511-09-1
1.2.1 Relevant identified uses
Laboratory use
supplier name
LGC Limited
Emergency telephone
1-800-424-9300, +1 703-741-5970
Icons in SDS
Company Information
company name
LGC Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gb@lgcstandards.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H311, H331, H361, H362
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Contains
Ergocryptine
Signal word
Danger
Hazard statements
H301 - Toxic if swallowed H311 - Toxic in contact with skin H331 - Toxic if inhaled H361 - Suspected of damaging fertility or the unborn child H362 - May cause harm to breast-fed children
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapours/spray P263 - Avoid contact during pregnancy and while nursing P280 - Wear protective gloves/protective clothing/eye protection/face protection P301 + P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor P403 + P233 - Store in a well-ventilated place. Keep container tightly closed
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Regulation (EC) No 1272/2008 Acute toxicity - Oral Category 3 - (H301) Acute toxicity - Dermal Category 3 - (H311) Acute toxicity - Inhalation (Dusts/Mists) Category 3 - (H331) Reproductive toxicity Category 2 - (H361) Effects on or via lactation Yes - (H362)
